KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$0.02.

  • Castle Biosciences' EPS (Weighted Average and Diluted) fell 12500.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 31428.57%. This contributed to the annual value of $0.62 for FY2024, which is 12914.27% up from last year.
  • Castle Biosciences' EPS (Weighted Average and Diluted) amounted to -$0.02 in Q3 2025, which was down 12500.0% from $0.15 recorded in Q2 2025.
  • Castle Biosciences' 5-year EPS (Weighted Average and Diluted) high stood at $0.33 for Q4 2024, and its period low was -$1.1 during Q1 2023.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.32, with a median of -$0.25 in 2021.
  • Per our database at Business Quant, Castle Biosciences' EPS (Weighted Average and Diluted) plummeted by 106666.67% in 2023 and then surged by 46423.02% in 2024.
  • Over the past 5 years, Castle Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.25 in 2021, then tumbled by 216.0% to -$0.79 in 2022, then soared by 88.61% to -$0.09 in 2023, then surged by 464.23% to $0.33 in 2024, then crashed by 106.1% to -$0.02 in 2025.
  • Its last three reported values are -$0.02 in Q3 2025, $0.15 for Q2 2025, and -$0.9 during Q1 2025.